Twitter | Search | |
Biomed & Tech Stock Focus
News and analysis of biomedical, pharmaceutical, and technology equities
4,476
Tweets
422
Following
211
Followers
Tweets
Biomed & Tech Stock Focus 12h
Building better CAR-T therapies
Reply Retweet Like
Biomed & Tech Stock Focus 13h
Southern Company Is Being Ignored By The Market
Reply Retweet Like
Biomed & Tech Stock Focus 18h
. Big Tech is suffering from ‘mean reversion.’ And the downdraft isn’t over yet – Fortune
Reply Retweet Like
Biomed & Tech Stock Focus 18h
ILJIN SNT Co. Ltd. Announces Filing of Early Warning Report Related to Aurinia Pharmaceuticals Inc.
Reply Retweet Like
Biomed & Tech Stock Focus 18h
No Joke: Pinterest Has More Monthly Users Than Twitter
Reply Retweet Like
Biomed & Tech Stock Focus 21h
With U.S. elections nearing, European pharma giants brace for potential pricing action: analysts
Reply Retweet Like
Biomed & Tech Stock Focus 22h
HC Wainwright Keeps Buy Rating On Akero, $62 PT
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Maxim Group Thinks Monopar Therapeutics Stock Will Recover
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Axsome Therapeutics Receives It’s Third Buy Rating In A Row; William Blair Says Buy
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Biotech Short Sellers Hike Their Bets
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Biotech Taysha Gene Therapies Climbs in Trading Debut via
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Top Biotech Penny Stocks To Watch For October 2020 via
Reply Retweet Like
Biomed & Tech Stock Focus 22h
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments via Labiotech_eu
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Exact gatecrashes the liquid biopsy party
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Ophthalmology Biotech Tarsus Pharma Files For IPO
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam) ... via
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Genetron: 3 Reasons To Stay Bullish On China's Early-Stage Cancer Screening
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Intel - Oversold On Delay Announcements
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Cloudera: Strong Margin Expansion, Great Recurring Revenues, Buy The Dip
Reply Retweet Like
Biomed & Tech Stock Focus Sep 25
Satsuma: Not All Over For Migraine Treatment Despite Trial Failure
Reply Retweet Like